516 related articles for article (PubMed ID: 11702899)
1. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
Cataliotti A; Malatino LS; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli SS; Heublein DM; Lainchbury JG; Leskinen HK; Bailey KR; Redfield MM; Burnett JC
Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
Mallamaci F; Zoccali C; Tripepi G; Benedetto FA; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Stancanelli B; Malatino LS;
Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
[TBL] [Abstract][Full Text] [Related]
3. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
[TBL] [Abstract][Full Text] [Related]
4. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
[TBL] [Abstract][Full Text] [Related]
5. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
Haug C; Metzele A; Steffgen J; Kochs M; Hombach V; Grünert A
Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease.
Tripepi G; Mattace-Raso F; Mallamaci F; Benedetto FA; Witteman J; Malatino L; Zoccali C
Hypertension; 2009 Oct; 54(4):818-24. PubMed ID: 19635983
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of brain natriuretic peptides in hemodialysis patients.
Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
[TBL] [Abstract][Full Text] [Related]
8. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
[TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.
Almeida P; Azevedo A; Rodrigues R; Dias P; Friões F; Vazquez B; Abreu-Lima C; Bettencourt P; Barros H
Rev Port Cardiol; 2003 Mar; 22(3):327-36. PubMed ID: 12847875
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
[TBL] [Abstract][Full Text] [Related]
12. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of brain natriuretic peptides and cardiac troponin in hemodialysis patients.
Resić H; Ajanović S; Kukavica N; Masnić F; Corić A
Bosn J Basic Med Sci; 2009 May; 9(2):137-41. PubMed ID: 19485946
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment].
Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A
Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326
[TBL] [Abstract][Full Text] [Related]
15. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
Haug C; Metzele A; Steffgen J; Grünert A
Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
[TBL] [Abstract][Full Text] [Related]
16. [Factors that influence the serum of atrial natriuretic peptide and brain natriuretic peptide concentrations--is there a specific marker for senile patients?].
Sayama H; Nakamura Y; Saitou N; Doi Y; Matsukura S; Sakurai H; Kinoshita M
Nihon Ronen Igakkai Zasshi; 1998 Nov; 35(11):851-7. PubMed ID: 10064973
[TBL] [Abstract][Full Text] [Related]
17. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
Pedersen EB; Bacevicius E; Bech JN; Solling K; Pedersen HB
Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
[TBL] [Abstract][Full Text] [Related]
18. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.
Nagaya N; Nishikimi T; Goto Y; Miyao Y; Kobayashi Y; Morii I; Daikoku S; Matsumoto T; Miyazaki S; Matsuoka H; Takishita S; Kangawa K; Matsuo H; Nonogi H
Am Heart J; 1998 Jan; 135(1):21-8. PubMed ID: 9453517
[TBL] [Abstract][Full Text] [Related]
19. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H
Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
[TBL] [Abstract][Full Text] [Related]
20. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction.
Tulevski II; Groenink M; van Der Wall EE; van Veldhuisen DJ; Boomsma F; Stoker J; Hirsch A; Lemkes JS; Mulder BJ
Heart; 2001 Jul; 86(1):27-30. PubMed ID: 11410557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
